< Back To News
April 24, 2024

Mark Adams, Ph.D.

Mark Adams is a venture partner at Two Bear Capital, where he focuses on life sciences, artificial intelligence, and cybersecurity companies. Mark was most recently COO and CTO at Adaptive Biotechnologies, a public biotechnology company in Seattle, WA. He has previously had C-Suite roles in several biotechnology companies, as well as leading a consulting practice at Booz Allen Hamilton. He has also led artificial intelligence and data science teams in finance at Bridgewater Associates and Leerink Partners. Mark holds a Ph.D. in molecular biology and focused his undergraduate studies in the area of computer science including research on artificial intelligence.